Servier joins the fight against diabetes
31/10/2023
Homepage fron
Our news
203
employees
14
countries in which the Subsidiary
medicines are distributed
+20%
20% of the brand-name
revenue in R&D every year
€4.7 billion
euros in revenue in 2020/2021 comprising €3.3
billion for brand-name medicines and €1.4 billion
for generic medicines
4 therapeutic areas
Oncology, Neuroscience, Immuno-
inflammation, Cardiometabolism
OUR COMMITMENTS
At Servier, we believe that providing future generations with a healthier world is at the heart of our mission. As a leading pharmaceutical company, we work towards our purpose with passion, dedication and determination. This conviction is embodied first and foremost in the central place we give to the patient, but also in our ethics and compliance standards, and in our corporate social responsibility policy.